Neuberger Berman Group LLC Crispr Therapeutics Ag Transaction History

Neuberger Berman Group LLC

  • $118 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$100.84 - $161.89 $326,721 - $524,523
-3,240 Closed
0 $0
Q1 2021

May 13, 2021
BUY
$110.72 - $210.04 $71,746 - $136,105
648 Added 25.0%
3,240 $395,000
Q4 2020

Feb 10, 2021
BUY
$79.67 - $173.23 $12,189 - $26,504
153 Added 6.27%
2,592 $407,000
Q3 2020

Nov 12, 2020
BUY
$78.5 - $100.64 $191,461 - $245,460
2,439 New
2,439 $203,000

Others Institutions Holding CRSP

# of Institutions
549
Shares Held
56.3M
Call Options Held
2.91M
Put Options Held
2.47M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $4.21B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email